1. Amir RJ, Popkov M, Lerner RA, Barbas CF & Shabat D
Prodrug activation gated by a molecular "OR" logic trigger.
Angew. Chem. Int. Ed. 44 (2005) 4378-4381

2. Debler EW, Ito S, Seebeck FP, Heine A, Hilvert D & Wilson IA
Structural origins of efficient proton abstraction from carbon by a catalytic antibody.
Proc. Natl. Acad. Sci. USA 102 (2005) 4984-4989

3. Dickerson TJ, Kaufmann GF & Janda KD
Bacteriophage-mediated protein delivery into the central nervous system and its application in immunopharmacotherapy.
Exp. Opin. Biol. Therap. 5 (2005) 773-781

4. Gollinelli-Pimpaneau B
Structure of a pseudomerohedrally twinned monoclinic crystal from a pyridoxal phosphate-dependent catalytic antibody.
Acta Crystallogr. D 61 (2005) 472-476

5. Gorbunov DV, Karataeva NA, Buneva VN & Nevinsky GA
Lipid kinase activity of antibodies from milk of clinically healthy human mothers.
Biochim. Biophys. Acta 1735 (2005) 153-166

6. Greaves R & Warwicker J
Active site identification through geometry-based and sequence profile-based calculations: burial of catalytic clefts.
J. Mol. Biol. 349 (2005) 547-557

7. Haba K, Popkov M, Shamis M, Lerner RA, Barbas CF & Shabat D
Single-triggered trimeric prodrug.
Angew. Chem. Int. Ed. 44 (2005) 716-720

8. Haney M & Kosten TR
Therapeutic vaccines for subtance dependence.
Drug Discover. Today 2 (2005) 65-69

9. Hanson CV, Nishiyama Y & Paul S
Catalytic antibodies and their applications.
Curr. Opin. Biotechnol. 16 (2005) 631-636

10. Hifumi E, Hatiuchi K, Okuda T, Nichizono A, Okamura Y & Uda T
Specific degradation of H. pylori urease by a catalytic antibody light chain.
FEBS J. 272 (2005) 4497-4505

11. Hosomi N, Kawara-Konishi Y, Kawano R, Fujii I & Suzuki H
Site-directed mutagenesis study of the antibody 2D7 which catalyzes a reaction for insertion of Cu2+ into mesoporphyrin.
J. Biosci. Bioeng. 99 (2005) 222-229

12. Ikhmyangan EN, Vasilenko NL, Buneva VN & Nevinsky GA
IgG antibodies with peroxidase-like activity from the sera of healthy Wistar rats.
FEBS Lett. 579 (2005) 3960-3964

13. Ishida T, Shinada T & Ohfune Y
Synthesis of novel amino squaric acids via addition of dianion enolates derived from N-boc amino acid esters.
Tetrahedron Lett. 46 (2005) 311-314

14. Jovic F, Louise L, Mioskowski C &Renard PY
Immunologically driven antibodies chemical engineering: design and synthesis of a hapten aimed at nerve agent hydrolysis
Tetrahedron Lett 46 (2005) 6809-6814

15. Kalinina EV, Ponmarenko NA, Durova OM, Paleev FN, Vorobiev II, Kekenadze NN, Shogenov ZS, Zemtsova ME, Gnuchev NV & Gabibov AG
Catalytic autoantibodies in autoimmune myocarditis: clinical and pathogenic implications.
Ter. Arkh. 77 (2005) 65-70

16. Kato K, Saito T, Seelan S, Tomita M & Yokogawa Y
Reaction properties of catalytic antibodies encapsulated in organo substituted SiO2 sol-gel materials.
J. Biosci. Bioeng. 100 (2005) 478-480

17. Kawai Y, Hayashi M & Tokitoh N
Chlorodinitrophenylhydrazine, a useful crystalline agent for absolute configuration determination of various chiral ketones.
Tetrahedron 61 (2005) 5049-5055

18. Lacroix-Desmazes S, Bayry J, Kaveri S, Hayon-Sonsino D, Thorenoor N, Charpentier J, Luyt CE, Mira JP, Nagaraja V, Kazatchkine MD, Dhainaut JF & Mallet VO
High levels of catalytic antibodies correlate with favorable outcome in sepsis.
Proc. Natl. Acad. Sci. USA 102 (2005) 4109-4113

19. Marti S, Andres J, Moliner V, Silla E, Tunon M & Bertran J
Towards a rational design of antibody catalysts through computational chemistry.
Angew. Chem. Int. Ed. 44 (2005) 904-909

20. McGuire KL & Holmes DS
Role of complementary proteins in autoimmunity: an old idea re-emerges with new twists.
Trends Immunol. 26 (2005) 367-372

21. Misikov VK, Kimova MV, Durova OM, Gabibov AG, Suchkov SV, Vorobiev II & Ponomarenko NA
Catalytic autoantibodies in multiple slerosis: pathogenic and clinical aspects.
Bull. Exp. Biol. Med. 139 (2005) 85-88

22. Mitsuda Y, Tsuruhata K, Hifumi E, Takagi M & Uda T
Investigation of active form of catalytic antibody light chain 41S-2-L.
Immunol. Lett. 96 (2005) 63-71

23. Mu Y, Song D, Li Y, Zhang HQ, Li W, Luo GM & Jin QH
Selection of phage antibodies with GPX activity by combination of phage displayed antibody library with chemical modification and their characterization using a surface plasmon resonance biosensor.
Talanta 66 (2005) 181-187

24. Nishiyama Y, Mitsuda Y, Taguchi H, Planque S, Hara M, Karle S, Hanson CV, Uda T & Paul S
Broadly distributed nucleophilic reactivity of proteins coordinated with specific ligand binding activity.
J. Mol. Recognit. 18 (2005) 295-306

25. Odintsova ES, Buneva VN & Nevinsky GA
Casein-hydrolyzing activity of sIgA antibodies from human milk.
J. Mol. Recognit. 18 (2005) 413-421

26. Paul S, Nishiyama Y, Planque S, Karle S, Tagushi H, Hanson C & Weksler ME
Antibodies as defensive enzymes.
Springer Semin. Immunopathol. 26 (2005) 485-503

27. Pauyo T, Hilinski GJ, Chiu PT, Hansen DE, Choi YJ, Ratner DI, Shah-Mahoney N, Southern CA & O'Hara PB
Genetic and fluorescence studies of affinity maturation in related antibodies.
Mol. Immunol. (2005) in press

28. Pellequer JL, Chen SWW, Keum YS, Karu AE, Li QX & Roberts VA
Structural basis for preferential binding of non-ortho-substituted polychlorinated biphenyls by the monoclonal antibody S2B1.
J. Mol. Recognit. 18 (2005) 282-294

29. Rodgers CJ, Mee JM, Kaufmann GF, Dickerson TJ & Janda KD
Toward cocaine esterase therapeutics.
J. Am. Chem. Soc. 127 (2005) 10016-10017

30. Saito M, Okazaki I, Oda M & Fujii I
A free energy calculation study of the effect of H->F substitution on binding affinity in ligand-antibody interactions.
J. Comput. Chem. 26 (2005) 272-282

31. Sakakura M, Takahashi H, Terasawa H, Takeushi K, Fujii I & Shimada I
Backbone resonance assignments for the scFv fragment of catalytic antibody 6D9 complexed with a transition state analogue.
J. Biomol. NMR 33 (2005) 282

32. Saphier S, Hu Y, Sinha SC, Houk KN & Keinan E
Origin of selectivity in the antibody 20F10-catalyzed Yang cyclization.
J. Am. Chem. Soc. 127 (2005) 132-145

33. Seebeck FP & Hilvert D
Positional ordering of reaction groups contributes significantly to the efficiency of proton transfer at an antibody active site.
J. Am. Chem. Soc. 127 (2005) 1307-1312

34. Sethi V, Onyuksel H & Rubinstein I
Liposomal vasoactive intestinal peptide.
Methods Enzymol. 391 (2005) 377-395

35. Sicard R, Chen LS, Marsaiolo AJ & Reymond JL
A fluorescence-based assay for Baeyer-Villiger monooxygenases, hydroxylases and lactonases.
Adv. Synth. Catal. 347 (2005) 1041-1050

36. Silva FA & Gouverneur V
Elongation of beta-hydroxyenones by cross-metathesis.
Tetrahedron Lett. 46 (2005) 8705-8709

37. Suchkov SV, Alekberova ZS, Paleev FN, Naumova TE, Misikov VK, Kriazheva ES, Ponomarenko NA & Gabibov AG
Achievements and propects of clinical abzymology.
Vestn. Ross. Akad. Med. Nauk. 2005 (2005) 38-43

38. Tanaka F & Barbas CF
Enamine-based reactions using organocatalysts: from aldolase antibodies to small amino acid and amine catalysts.
J. Synth. Org. Chem. Japan 63 (2005) 709-721

39. Thomas CM & Ward TR
Design of artificial metalloenzymes.
Appl. Organomet. Chem. 19 (2005) 35-39

40. Toti P, Petri A, Pelaia V, Osman AM, Paolini M & Bauer C
A linearization method for low catalytic activity enzyme kinetic analysis.
Biophys. Chem. 114 (2005) 245-251

41. Xu Y, Yamamoto N, Ruiz DI, Kubitz DS & Janda KD
Squaric monoamide monoester as a new class of reactive immunization haptens for catalytic antibodies.
Bioorg. Med. Chem. Lett. 15 (2005) 4304-4307

42. You Y
Podophyllotoxin derivatives: current synthetic approaches of new anticancer agents.
Curr. Pharm. Des. 11 (2005) 1695-1717

43. Zan CG, Deng SX, Skiba JG, Hayes BA, Tschampel SM, Shields GC & Landry DW
First-principle studies of intermolecular and intramolecular catalysis of protonated cocaine.
J. Comput. Chem. 26 (2005) 980-986

44. Zhang Y, Li ZS, Sun M, Zheng QC & Sun CC
Molecular simulation studies of a selenium-containing scFv catalytic antibody that mimics glutathione peroxidase.
Biochim. Biophys. Acta 1747 (2005) 27-34

45. Zheng L, Manetsch R, Woggon WD, Baumann U & Reymond JL
Mechanistic study of proton transfer and hysteresis in catalytic antibody 16E7 by site-directed mutagenesis and homology modeling.
Bioorg. Med. Chem. 13 (2005) 1021-1029